Invention Grant
- Patent Title: Crystalline bis- and tris-hydrochloride salt of elamipretide
-
Application No.: US16259575Application Date: 2019-01-28
-
Publication No.: US10676506B2Publication Date: 2020-06-09
- Inventor: Scott M. Duncan
- Applicant: Stealth BioTherapeutics Corp.
- Applicant Address: MC Monte Carlo
- Assignee: Stealth BioTherapeutics Corp.
- Current Assignee: Stealth BioTherapeutics Corp.
- Current Assignee Address: MC Monte Carlo
- Agency: Foley Hoag LLP
- Main IPC: C07K7/00
- IPC: C07K7/00 ; C07K5/11 ; C07K1/14
Abstract:
Disclosed are crystalline forms of the bis- and tris-(hydrochloride) salts of D-Arg-Tyr(2,6-DiMe)-Lys-Phe-NH2, which is also known as MTP-131.
Public/Granted literature
- US20190233474A1 CRYSTALLINE BIS- AND TRIS-HYDROCHLORIDE SALT OF ELAMIPRETIDE Public/Granted day:2019-08-01
Information query
